Skip to content

Work

Case studies, outcome first.

Four pieces of shipped product work. Each one foregrounds discovery, strategy and the result, with what I owned stated plainly.

File 01

Life Sciences · Enterprise SaaS

2024 – PresentQinecsa Solutions

Scaling a flagship AI SaaS platform from 1 to 10 across four geographies

Unified four business functions, previously run on four separate legacy products, into one AI SaaS platform and launched it for a major life-sciences customer across four geographies, generating £4M in revenue and £10M in projected annual savings.

  • 1 to 10
  • Platform strategy
  • P&L
  • Global rollout
£4MRevenue generatedacross four geographies
£10MCost savingsprojected annually, on a £3M project cost
4 to 1Legacy products consolidatedfour functions, one platform
4Geographies launchedJapan, Germany, UK, Denmark
Read case study
File 02

Applied AI · NLP & RAG on AWS

2024 – PresentQinecsa Solutions

An AI product suite that saved £1.5M and lifted accuracy 30%

Shipped three production AI products, AI-Semantic Search, AI-Intake and AI-Summarizer, saving over £1.5M and lifting extraction accuracy by around 30%.

  • Applied AI
  • RAG
  • NLP
  • Model evaluation
£1.5MCost savingsacross the AI suite
90%Faster searchAI-Semantic Search
+30%Extraction accuracyAI-Intake
3AI products shippedon AWS
Read case study
File 03

Enterprise SaaS · Growth & Stabilisation

2024 – PresentQinecsa Solutions

A turnaround that took first-time completion from 60% to 94%

Reimagined failing workflows, cleared 18 months of technical debt, and secured a £500K repeat engagement on a stabilised product.

  • Turnaround
  • Workflow redesign
  • Tech debt
  • Retention
60 to 94%First-time completion
£500KRepeat engagement secured
20+Critical gaps closedin four months
60%Support volume reduced
Read case study
File 04

Life Sciences · Data Governance & Regulatory

2022 – 2024KPMG · client: GSK

Closing EU AI Act gaps to protect ~£35M in regulatory exposure

Embedded as product lead on GSK's Development Data Fabric, closing EU AI Act gaps and protecting roughly £35M in regulatory exposure.

  • Regulatory
  • Data governance
  • Discovery
  • Localisation
~£35MRegulatory exposure protected≈7% of GSK UK revenue
30+Discovery workshopsover six months
2Regional expansions unlockedGermany & Netherlands
6 moProgramme duration
Read case study

Next step

Looking for a PM who owns the strategy and ships the product?

Open to Senior PM, AI PM and Product Builder roles in London or UK-remote. Recognised Global Talent UK, with full working rights in the UK.

Get in touchsapnil.bhatnagar@gmail.com